Biomedical aspects of targeted delivery of drugs to pulmonary endothelium

Bibliography

• FISHMAN AP: A century of pulmonary hemodynamics. Am. J. Respir. Grit. Care Med. (2004) 170(2):109–113.
   Google Scholar
• LEFF JA, BAER JW, BODMAN ME et al Interleukin-l-induced lung neutrophil accumulation and oxygen metabolite-mediated lung leak in rats. Am. Physiol (1994) 266(1 Pt 1):L2–L8.
   Google Scholar
• LOUIE S, HALLIWELL B, CROSS CE: Adult respiratory distress syndrome: a radical perspective. Adv. Pharmacol (1997) 38:457–490.
   Google Scholar
• HEFFNER JE, REPINE JE: Pulmonary strategies of antioxidant defense. Am. Rev Respir. Dis. (1989) 140(2):531–554.
   Google Scholar
• ROBERTS KE, HAMELE-BENA D, SAQI A, STEIN CA, COLE RP: Pulmonary tumor embolism: a review of the literature. Am. I Med. (2003) 115(3):228–232.
   Google Scholar
• KAWAGUCHI T: Cancer metastasis: characterization and identification of the behavior of metastatic tumor cells and the cell adhesion molecules, including carbohydrates. Curr. Drug Targets Cardiovasc. Haematol Disord. (2005) 5(1):39–64.
   Google Scholar
• BAKER RR, CZOPF L, JILLING T et al Quantitation of alveolar distribution of liposome-entrapped antioxidant enzymes. Am. J. Physiol (1992) 263(5 Pt 1):L585–L594.
   Google Scholar
• BRISCOE P, CANIGGIA I, GRAVES A et al Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes. Am. Physic] (1995) 268(3 Pt 1):L374–L380.
   Google Scholar
• EDWARDS DA, BEN-JEBRIA A, LANGER R: Recent advances in pulmonary drug delivery using large, porous inhaled particles. J. Appl. Physic] (1998) 85(2):379–385.
   Google Scholar
• REEVES JT, LINEHAN JH, STENMARK KR: Distensibility of the normal human lung circulation during exercise. Am. I Physic] Lung Cell. Mol. Physic] (2005) 288(3):L419–L425.
   Google Scholar
• REMETZ MS, CLEMAN MW, CABIN HS: Pulmonary and pleural complications of cardiac disease. Clio. Chest Med. (1989) 10(4):545–592.
   Google Scholar
• BRIGHAM KL, MEYRICK B: Endotoxin and lung injury. Am. Rev Respir. Dis. (1986) 133(5):913–927.
   Google Scholar
• SKEIE B, ASKANAZI J, ROTHKOPF MM et al Intravenous fat emulsions and lung function: a review. Grit. Care Med. (1988) 16(2):183–194.
   Google Scholar
• LUSH CW, KVIETYS PR: Microvascular dysfunction in sepsis. Microcirculation (2000) 7(2):83–101.
   Google Scholar
• SHIMODA LA, SHAM JS, SYLVESTER JT: Altered pulmonary vasoreactivity in the chronically hypoxic lung. Physic] Res. (2000) 49(5):549–560.
   Google Scholar
• WAYPA GB, SCHUMACKER PT: 0(2) sensing in hypoxic pulmonary vasoconstriction: the mitochondrial door re-opens. Respir. Physic] Neurobiol (2002) 132(1):81–91.
   Google Scholar
• GAO Y, RAJ JU: Role of veins in regulation of pulmonary circulation. Am. I Physic] Lung Cell. Mol. Physic] (2005) 288 (2):L213–L226.
   Google Scholar
• POZNANSKY MJ, JULIANO RL: Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol Rev (1984) 36(4):277–336.
   Google Scholar
• ABUCHOWSKI A, MCCOY JR, PALCZUK NC, VAN EST, DAVIS FF: Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem. (1977) 252(11):3582–3586.
   Google Scholar
• OLSON NC, GRIZZLE MK, ANDERSON DL: Effect of polyethylene glycol-superoxide dismutase and catalase on endotoxemia in pigs../. Appl. Physiol (1987) 63(4):1526–1532.
   Google Scholar
• FC JR: The future of liposomal drug delivery. Biotechnol Appl Biochem. (1990) 12(5):496–500.
   Google Scholar
• LASIC DD: Novel applications of liposomes. Trends Biotechnol (1998) 16(7):307–321.
   Google Scholar
• CORVO ML, BOERMAN OC, OYEN WJ et al Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. Bloch/m. Biophys. Acta (1999) 1419(2):325–334.
   Google Scholar
• DISCHER BM, WON YY, EGE DS et al Polymersomes: tough vesicles made from diblock copolymers. Science (1999) 284(5417):1143–1146.
   Google Scholar
• LANGER R: Drug delivery and targeting. Nature (1998) 392(6679 Suppl.):5–10.
   Google Scholar
• BARTUS RT, TRACY MA, EMERICH DF, ZALE SE: Sustained delivery of proteins for novel therapeutic agents. Science (1998) 281(5380):1161–1162.
   Google Scholar
• TORCHILIN VP: Strategies and means for drug targeting: an overview. In: Biomedical Aspects of Drug Targeting. VR Muzykantov et al (Eds) Kluwer Academic Publishers, Boston, MA, USA (2003):3–26.
   Google Scholar
• CRAPO JD, DELONG DM, SJOSTROM K, HASLER GR, DREW RT: The failure of aerosolized superoxide dismutase to modify pulmonary oxygen toxicity. Am. Rev Respir. Dis. (1977) 115(6):1027–1033.
   Google Scholar
• HAUN SE, KIRSCH JR, HELFAER MA, KUBOS KL, TRAYSTMAN RJ: Polyethylene glycol-conjugated superoxide dismutase fails to augment brain superoxide dismutase activity in piglets. Stroke (1991) 22(5):655–659.
   Google Scholar
• HUO D, DENG S, LI L, JI J: Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting. Int. J. Pharm. (2005) 289(1–2)63–67.
   Google Scholar
• MULLER DW, GORDON D, SAN H et al Catheter-mediated pulmonary vascular gene transfer and expression. Circ. Res. (1994) 75(6):1039–1049.
   Google Scholar
• MUZYKANTOV VR: Immunotargeting of drugs to the pulmonary vascular endothelium as a therapeutic strategy. Pathophysiology (1998) 5(1):15–33.
   Google Scholar
• •This and four subsequent articles and chapters provide overviews of endothelial targets and drug delivery systems for targeted delivery of antioxidant and anti-thrombotic agents, imaging probes and genetic materials to the pulmonary vascular endothelium.
   Google Scholar
• MUZYKANTOV VR, DANILOV S: Delivery of drugs and genes to vascular endothelium. In: Encyclopedia of the Microvasculature. D Sherpo et al. (Eds) (2005) (In press).
   Google Scholar
• MURO S, MUZYKANTOV VR, MURCIANO JC: Characterization of endothelial internalization and targeting of antibody-enzyme conjugates in cell cultures and in laboratory animals. Methods Mol Biol. (2004) 283:21–36.
   Google Scholar
• MURO S, MUZYKANTOV VR: Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules. Curr. Pharmacol Dec. (2005) 11(18):2383–2401.
   Google Scholar
• PANYAM J, LABHASETWAR V: Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deity Rev (2003) 55(3):329–347.
   Google Scholar
• MURO S, KOVAL M, MUZYKANTOV V: Endothelial endocytic pathways: gates for vascular drug delivery. Curr. Vasc. Pharmacol (2004) 2(3):281–299.
   Google Scholar
• •This article reviews molecular and cellular mechanisms involved in internalisation and subsequent intracellular traffic of endothelial ligands via diverse endocytotic pathway, in specific context of vascular immunotargeting and drug delivery.
   Google Scholar
• CARON PC, LAIRD W, CO MS et al Engineered humanized dimeric forms of IgG are more effective antibodies. J. Exp. Med. (1992) 176(4):1191–1195.
   Google Scholar
• MUZYKANTOV VR: Targeting pulmonary endothelium. In: Biomedical Aspects of Drug Targeting. VR Muzykantov et al. (Eds), Kluwer Academic Publishers, Boston, MA, USA (2002):129–148.
   Google Scholar
• MUZYKANTOV VR: Delivery of antioxidant enzyme proteins to the lung. Antioxidants Redox Signaling (2001) 3(1):39–62.
   Google Scholar
• MUZYKANTOV VR: Targeting of superoxide dismutase and catalase to vascular endothelium. J. Control Release (2001) 71(1):1–21.
   Google Scholar
• DANILOV SM, MARTYNOV AV, KLIBANOV AL et al Radioimmunoimaging of lung vessels: an approach using indium-111-labeled monoclonal antibody to angiotensin-converting enzyme../. Nucl. Med. (1989) 30(10):1686–1692.
   Google Scholar
• •This is the first of a series of publications from Danilov's group that established ACE as a candidate determinant for targeted drug delivery to the pulmonary endothelium. This particular study explored visualisation of pulmonary vasculattu•e by anti-ACE radio-immunoscintigraphy, a methodology that has later been successfully employed in human studies using radiolabelled anti-ACE.
   Google Scholar
• DANILOV SM, MUZYKANTOV VR, MARTYNOV AV et al Lung is the target organ for a monoclonal antibody to angiotensin-converting enzyme. Lab. Invest. (1991) 64(1):118–124.
   Google Scholar
• DANILOV SM, GAVRILYUK VD, FRANKE FE et al Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Am. J. Physiol (2001) 280(6 Pt 1):L1335–L1347.
   Google Scholar
• DANILOV S, ATOCHINA E, HIEMISCH H et al Interaction of mAb to angiotensin-converting enzyme (ACE) with antigen in vitro and in vivo: antibody targeting to the lung induces ACE antigenic modulation. Int. Immunol (1994) 6(8):1153–1160.
   Google Scholar
• KENNEL SJ, FALCIONI R, WESLEY JW:Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts. Cancer Res. (1991) 51(5):1529–1536.
   Google Scholar
• KENNEL SJ, BULTMAN S, KABALKA G: Rat monoclonal antibody distribution in mice: an epitope inside the lung vascular space mediates very efficient localization. Int. I Rad. Appl. Instrum. B (1990) 17(2):193–200.
   Google Scholar
• CHRISTOFIDOU-SOLOMIDOU M, SCHERPEREEL A et al Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigration. Am. Pathol (2002) 160(3):1155–1169.
   Google Scholar
• ERDOS EG: Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture. Hypertension (1990) 16(4):363–370.
   Google Scholar
• LAURSEN JB, RAJAGOPALAN S, GALIS Z et al Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation (1997) 95(3):588–593.
   Google Scholar
• HEITSCH H, BROVKOVYCH S, MALINSKI T, WIEMER G: Angiotensin-(1-7)-stimulated nitric oxide and superoxide release from endothelial cells. Hypertension (2001) 37(1):72–76.
   Google Scholar
• MUZYKANTOV VR, DANILOV SM: Targeting of radiolabeled monoclonal antibody against ACE to the pulmonary endothelium. In: Handbook of Targeted Delivery of ImagingAgents. V Torchilin (Ed.), CRC Press, Boca Raton, FL, USA (1995):465–485.
   Google Scholar
• •This chapter summarises 10 years of research in Danilov's group focused on vascular immunotargeting to ACE, and provides an overview of massive amounts of animal data and limited results of human studies using anti-ACE, including imaging of radiolabelled anti-ACE in normal volunteers and sarcoidosis patients.
   Google Scholar
• REYNOLDS PN, NICKLIN SA, KALIBEROVA L et al Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo. Nat. Biotechnol (2001) 19(9):838–842.
   Google Scholar
• •This and subsequent paper introduce the concept of retargeting of adenoviral gene therapy means to the pulmonary vasculature using hetero-conjugate consisting of anti-ACE (which directs viruses to the pulmonary endothelium) and antiviral antibody (which couples anti-ACE to virus and blocks natural viral tropism to hepatic receptors).
   Google Scholar
• REYNOLDS PN, ZINN KR, GAVRILYUK VD et al A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo. Mol Ther. (2000) 2(6):562–578.
   Google Scholar
• NICKLIN SA, WHITE SJ, WATKINS SJ, HAWKINS RE, BAKER AH: Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display. Circulation (2000) 102(2):231–237.
   Google Scholar
• WHITE SJ, NICKLIN SA, BUNING H et al Targeted gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors. Circulation (2004) 109(4):513–519.
   Google Scholar
• WORK LM, NICKLIN SA, WHITE SJ, BAKER AH: Use of phage display to identify novel peptides for targeted gene therapy. Methods Enzymol (2002) 346:157–176.
   Google Scholar
• WORK LM, RITCHIE N, NICKLIN SA, REYNOLDS PN, BAKER AH: Dual targeting of gene delivery by genetic modification of adenovirus serotype 5 fibers and cell-selective transcriptional control. Gene Ther. (2004) 11(16):1296–1300.
   Google Scholar
• OLSON SC, DOWDS TA, PINO PA, BARRY MT, BURKE-WOLIN T: ANG II stimulates endothelial nitric oxide synthase expression in bovine pulmonary artery endothelium. Am. Physiol (1997) 273(2 Pt 1):L315–L321.
   Google Scholar
• SADHUKHAN R, SANTHAMMA KR, REDDY P et al Unaltered cleavage and secretion of angiotensin-converting enzyme in tumor necrosis factor-alpha-converting enzyme-deficient mice." Biol. Chem. (1999) 274(15):10511–10516.
   Google Scholar
• BALYASNIKOVA IV, KARRAN EH, ALBRECHT RF 2 DANILOV SM: Epitope-specific antibody-induced cleavage of angiotensin-converting enzyme from the cell surface. Biochem. (2002) 362(Pt 3):585–595.
   Google Scholar
• •This experimental paper provides an explicit example of potential specific side effects of engaging target determinant, ACE, by antibodies inducing epitope-specific changes of ACE shedding. In different pathological conditions, this effect may lead to either beneficial (vasorelaxation, antioxidant effects) or harmful (oedema or vascular collapse) consequences, which should be taken into account in design of ACE-targeting drug delivery systems.
   Google Scholar
• WATANABE K, LAM G, KERESZTES RS, JAFFE EA: Lipopolysaccharides decrease angiotensin converting enzyme activity expressed by cultured human endothelial cells. J. Cell. Physiol (1992) 150(2):433–439.
   Google Scholar
• ATOCHINA EN, HIEMISCH HH, MUZYKANTOV VR, DANILOV SM: Systemic administration of platelet-activating factor in rat reduces specific pulmonary uptake of circulating monoclonal antibody to angiotensin-converting enzyme. Lung (1992) 170(6):349–358.
   Google Scholar
• CHEN X, CATRAVAS JD: Neutrophil-mediated endothelial angiotensin-converting enzyme dysfunction: role of oxygen-derived free radicals. Am..]: Physiol (1993) 265(3 Pt 1):L243–L249.
   Google Scholar
• MUZYKANTOV VR, ATOCHINA EN, ISCHIROPOULOS H, DANILOV SM, FISHER AB: Immunotargeting of antioxidant enzyme to the pulmonary endothelium. Proc. Nat] Acad. Sci. USA (1996) 93(10:5213–5218.
   Google Scholar
• ATOCHINA EN, BALYASNIKOVA IV, DANILOV SM et al Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress. Am. J. Physiol (1998) 275(4 Pt 1)1806–L817.
   Google Scholar
• ESMON CT: The roles of protein C and thrombomodulin in the regulation of blood coagulation." Biol. Chem. (1989) 264(9)4743–4746.
   Google Scholar
• BRISSON C, ARCHIPOFF G, HARTMANN ML et al Antibodies to thrombomodulin induce receptor-mediated endocytosis in human saphenous vein endothelial cells. Thromb. Haemost. (1992) 68(6)737–743.
   Google Scholar
• GUERMAZI S, MELLOULI F, TRABELSI S, BEJAOUI M, DELLAGI K: Anti-thrombomodulin antibodies and venous thrombosis. Blood Coagul Fibrinolysis (2004) 15(7):553–558.
   Google Scholar
• CHRISTOFIDOU-SOLOMIDOU M, SCHERPEREEL A, WIEWRODT R et al PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress. Am. Physiol (2003) 285(2, Pt 1):L283–L292.
   Google Scholar
• SCHERPEREEL A, WIEWRODT R, CHRISTOFIDOU-SOLOMIDOU M et al Cell-selective intracellular delivery of a foreign enzyme to endothelium in vivo using vascular immunotargeting. FASEB (2001) 15(2):416–426.
   Google Scholar
• ALBELDA SM: Endothelial and epithelial cell adhesion molecules. Am. J. Respir. Cell Mol Biol. (1991) 4(3):195–203.
   Google Scholar
• NEWMAN PJ: The biology of PECAM-1. Clin. Invest. (1997) 99(1):3–8.
   Google Scholar
• OSAWA M, MASUDA M, KUSANO K, WARA K: Evidence for a role of platelet endothelial cell adhesion molecule-1 in endothelial cell mechanosignal transduction: is it a mechanoresponsive molecule?' Cell Biol. (2002) 158(4):773–785.
   Google Scholar
• VAPORCIYAN AA, DELISSER HM, YAN HC et al Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science (1993) 262(5139):1580–1582.
   Google Scholar
• SCHERPEREEL A, ROME JJ, WIEWRODT R et al Platelet-endothelial cell adhesion molecule-l-directed immunotargeting to cardiopulmonary vasculature." Pharmacol Exp. Ther. (2002) 300(3)777–786.
   Google Scholar
• CHRISTOFIDOU-SOLOMIDOU M, PIETRA GG, SOLOMIDES CC et al Immunotargeting of glucose oxidase to endothelium in vivo causes oxidative vascular injury in the lungs. Am. J. Physiol. Lung Cell Mol. Physiol. (2000) 278(4)1794–L805.
   Google Scholar
• MUZYKANTOV VR, CHRISTOFIDOU-SOLOMIDOU M, BALYASNIKOVA I et al Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule I): a strategy for vascular immunotargeting of drugs. Proc. Natl. Acad. Li. USA (1999) 96(5)2379–2384.
   Google Scholar
• SWEITZER TD, THOMAS AP, WIEWRODT R et al Pecam-directed immunotargeting of catalase: specific, rapid and transient protection against hydrogen peroxide. Free Radical Biology Medicine (2003) 34(8):1035–1046.
   Google Scholar
• KOZOWER BD, CHRISTOFIDOU-SOLOMIDOU M, SWEITZER TD et al Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat. Biotechnol. (2003) 21(4):392–398.
   Google Scholar
• WIEWRODT R, THOMAS AP, CIPELLETTI L et al Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood (2002) 99(3):912–922.
   Google Scholar
• LI S, TAN Y, VIROONCHATAPAN E, PITT BR, HUANG L: Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody. Am. J. Physiol. Lung Cell Mol. Physiol. (2000) 278(3):L504–L511.
   Google Scholar
• ALMENAR-QUERALT A, DUPERRAY A, MILES LA, FELEZ J, ALTIERI DC: Apical topography and modulation of ICAM-1 expression on activated endothelium. Am. J. Pathol. (1995) 147(5):1278–1288.
   Google Scholar
• PANES J, PERRY MA, ANDERSON DC et al Regional differences in constitutive and induced ICAM-1 expression in vivo. Am. Physiol. (1995) 269(6 Pt 2):H1955–H1964.
   Google Scholar
• MURCIANO JC, MURO S, KONIARIS Let al ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface. Blood (2003) 101(10):3977–3984.
   Google Scholar
• BECK-SCHIMMER B, SCHIMMER RC, WARNER RL et al Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. (1997) 17(3):344–352.
   Google Scholar
• DOERSCHUK CM, QUINLAN WM, DOYLE NA et al The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. J. Immunol. (1996) 157(10):4609–4614.
   Google Scholar
• MULLIGAN MS, VAPORCIYAN AA, WARNER RL et al Compartmentalized roles for leukocytic adhesion molecules in lung inflammatory injury. I Immunol. (1995) 154(3):1350–1363.
   Google Scholar
• SASSO DE, GIONFRIDDO MA, THRALL RS et al Biodistribution of indium-111-labeled antibody directed against intercellular adhesion molecule-1. J. Nucl. Med. (1996) 37(4):656–661.
   Google Scholar
• VILLANUEVA FS, JANKOWSKI RJ, KLIBANOV S et al Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells. Circulation (1998) 98(1):1–5.
   Google Scholar
• BLOEMEN PG, HENRICKS PA, VAN BLOOIS L et al Adhesion molecules: a new target for immunoliposome-mediated drug delivery. FEBS Lett. (1995) 357(2):140–144.
   Google Scholar
• KISHIMOTO TK, ROTHLEIN R: Integrins, ICAMs, and selectins: role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites. Adv. Pharmacol. (1994) 25:117–169.
   Google Scholar
• STAUNTON DE, MERLUZZI VJ, ROTHLEIN R et al A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell (1989) 56(5):849–853.
   Google Scholar
• ROTHLEIN R, MAINOLFI EA, KISHIMOTO TK: Treatment of inflammation with anti-ICAM-1. Res. Immunol. (1993) 144(9):735–739; discussion 754–762.
   Google Scholar
• KAVANAUGH AF, DAVIS LS, JAIN RI et al A Phase I/II open label study of the safety and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis. J. Rheumatol. (1996) 23(8):1338–1344.
   Google Scholar
• LEFER DJ, FLYNN DM, ANDERSON DC, BUDA AJ: Combined inhibition of P-selectin and ICAM-1 reduces myocardial injury following ischemia and reperfusion. Am. .1 Physiol. (1996) 271(6 Pt 2):H2421–H2429.
   Google Scholar
• ZIMMERMAN GA, MCINTYRE TM, PRESCOTT SM: Adhesion and signaling in vascular cell-cell interactions. I Clin. Invest. (1996) 98(8):1699–1702.
   Google Scholar
• MURO S, WIEWRODT R, THOMAS A et al A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. j. Cell Sci. (2003) 116(8):1599–1609.
   Google Scholar
• •This and the following publications by Mum et al. describe molecular and cellular mechanisms involved in regulation of endothelial endocytosis and subsequent intracellular traffic of cargos internalised by CAM-endocytosis induced by multivalent binding of drug carriers to constitutively non-intemalisable cell adhesion molecules ICAM-1 and PECAM–1.
   Google Scholar
• MURO S, GAJEWSKI C, KOVAL M, MUZYKANTOV VR: ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. Blood (2005) 105(2):650–658.
   Google Scholar
• MURO S, CUI X, GAJEWSKI C et al Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress. Am. J. Physiol. Cell Physiol. (2003) 285(5):C1339–C1347.
   Google Scholar
• SPRINGER TA: Adhesion receptors of the immune system. Nature (1990) 346(6283):425–434.
   Google Scholar
• SPRAGG DD, ALFORD DR, GREFERATH R et al Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. Proc. Nati Acad. Sci. USA (1997) 94(16):8795–8800.
   Google Scholar
• KIELY JM, CYBULSKY MI, LUSCINSKAS FW, GIMBRONE MA Jr: Immunoselective targeting of an anti-thrombin agent to the surface of cytokine-activated vascular endothelial cells. Arterioscler. Thromb. Vase. Biol. (1995) 15(8):1211–1218.
   Google Scholar
• •This and other works from Gimbrone's group provided rationale for exploration of endothelial E-selectin as a determinant for selective delivery of drugs to vascular areas involved in inflammation and thrombosis.
   Google Scholar
• KUIJPERS TW, RALEIGH M, KAVANAGH T et al Cytokine-activated endothelial cells internalize E-selectin into a lysosomal compartment of vesiculotubular shape. A tubulin-driven process. Immunol. (1994) 152(10):5060–5069.
   Google Scholar
• STRALEY KS, GREEN SA: Rapid transport of internalized P-selectin to late endosomes the TGN: roles in regulating cell surface expression and recycling to secretory granules. J. Cell Biol. (2000) 151(1):107–116.
   Google Scholar
• ASMUTH EJ, SMEETS EF, GINSEL LA et al Evidence for endocytosis of E-selectin in human endothelial cells. Eur. Immunol. (1992) 22(10):2519–2526.
   Google Scholar
• KESSNER S, KRAUSE A, ROTHE U, BENDAS G: Investigation of the cellular uptake of E-selectin-targeted immunoliposomes by activated human endothelial cells. Biochim. Biophys. Acta (2001) 1514(2):177–190.
   Google Scholar
• EVERTS M, KOK RJ, ASGEIRSDOTTIR SA et al Selective intracellular delivery of dexamethasone into activated endothelial cells using an E-selectin-directed immunoconjugate. Immunol. (2002) 168(2):883–889.
   Google Scholar
• HARARI OA, WICKHAM TJ, STOCKER CJ et al Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin. Gene Ther. (1999) 6(5):801–807.
   Google Scholar
• KEELAN ET, HARRISON AA, CHAPMAN PT et al Imaging vascular endothelial activation: an approach using radiolabeled monoclonal antibodies against the endothelial cell adhesion molecule E-selectin. J. Nucl. Med. (1994) 35(2):276–281.
   Google Scholar
• •This animal study is one of the first of a large group of publications that explores potential utility of inducible endothelial cell adhesion molecules as targets for visualisation of sites of inflammation and pathological activation of vascular endothelium.
   Google Scholar
• LINDNER JR, SONG J, CHRISTIANSEN J et al Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation (2001) 104(17):2107–2112.
   Google Scholar
• LINDNER JR, KLIBANOV AL, LEY K: Targeting inflammation. In Biomedical aspects of drug targeting. VR Muzykantov et al. (eds) Kluwer Academic Pub., Boston USA (2003):149–172.
   Google Scholar
• GHITESCU L, JACOBSON BS, CRINE P: A novel, 85 kDa endothelial antigen differentiates plasma membrane macrodomains in lung alveolar capillaries. Endothelium (1999) 6(3):241–250.
   Google Scholar
• GHITESCU LD, CRINE P, JACOBSON BS: Antibodies specific to the plasma membrane of rat lung microvascular endothelium. Exp. Cell Res. (1997) 232(0:47–55.
   Google Scholar
• MURCIANO JC, HARSHAW DW, GHITESCU L, DANILOV SM, MUZYKANTOV VR: Vascular immunotargeting to endothelial surface in a specific macrodomain in alveolar capillaries. Am. J. Respir. Grit. Care Med. (2001) 164(7):1295–1302.
   Google Scholar
• MCINTOSH DP, TAN XY, OH P, SCHNITZER JE: Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc. Natl. Acad. Li. USA (2002) 99(4):1996–2001.
   Google Scholar
• •This paper introduces a strategy for targeting specific surface determinants localised in rat pulmonary vasculature in endothelial caveoli. In addition to enhanced effectiveness of drug delivery to pulmonary endothelial cells attained after Intravenous injection in rats, targeting caveoli facilitates internalisation of endothelium-bound materials and their transcellular traffic via a unique endocytotic pathway.
   Google Scholar
• RIEZMAN H, WOODMAN PG, VAN MEER G, MARSH M: Molecular mechanisms of endocytosis. Cell (1997) 91(6):731–738.
   Google Scholar
• PREDESCU D, PALADE GE: Plasmalemmal vesicles represent the large pore system of continuous microvascular endothelium. Am. .1 Physiol. (1993) 265(2 Pt 2):H725–H733.
   Google Scholar
• STAN RV: Structure and function of endothelial caveolae. Microsc. Res. Tech. (2002) 57(5):350–364.
   Google Scholar
• MINSHALL RD, TIRUPPATHI C, VOGEL SM, MALIK AB: Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function. Histochem. Cell Biol. (2002) 117(2):105–112.
   Google Scholar
• SCHNITZER JE: Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv. Drug Deify. Rev (2001) 49(3):265–280.
   Google Scholar
• SCHNITZER JE, MCINTOSH DP, DVORAK AM, LIU J, OH P: Separation of caveolae from associated microdomains of GPI-anchored proteins. Science (1995) 269(5229):1435–1439.
   Google Scholar
• MINSHALL RD, TIRUPPATHI C, VOGEL SM et al Endothelial cell-surface 8P60 activates vesicle formation and trafficking via G(0-coupled Src kinase signaling pathway. J. Cell Biol. (2000) 150(5):1057–1070.
   Google Scholar
• VOGEL SM, EASINGTON CR, MINSHALL RD et al Evidence of transcellular permeability pathway in microvessels. Microvasc. Res. (2001) 61(1):87–101.
   Google Scholar
• JOHN TA, VOGEL SM, TIRUPPATHI C, MALIK AB, MINSHALL RD: Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. Am. J. Physiol. Lung Cell. Mol. Physiol. (2003) 284(1)1187–L196.
   Google Scholar
• TIRUPPATHI C, SONG W, BERGENFELDT M, SASS P, MALIK AB: Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J. Biol. Chem. (1997) 272(40:25968–25975.
   Google Scholar
• PREDESCU D, PREDESCU S, MALIK AB: Transport of nitrated albumin across continuous vascular endothelium. Proc. Nati Acad. St". USA (2002) 99(21):13932–13937.
   Google Scholar
• •This paper, from one of the leading groups in the area of endothelial endocytosis and traffic via caveoli, describes facilitation of these mechanisms by chemically modified ligands of caveolar determinant, a paradigm potentially useful for pulmonary vascular drug delivery.
   Google Scholar
• DAVIES PF: Mechanisms involved in endothelial responses to hemodynamic forces. Atherosclerosis (1997) 131(Suppl.):S15–S17.
   Google Scholar
• BALYASNIKOVA IV, DANILOV SM, MUZYKANTOV VR, FISHER AB: Modulation of angiotensin-converting enzyme in cultured human vascular endothelial cells. In vitro Cell. Dev. Biol. Animal (1998) 34(7):545–554.
   Google Scholar
• WEI Z, COSTA K, AL-MEHDI AB et al Simulated ischemia in flow-adapted endothelial cells leads to generation of reactive oxygen species and cell signaling. Circ. Res. (1999) 85(8):682–689.
   Google Scholar
• MANEVICH Y, AL-MEHDI A, MUZYKANTOV V, FISHER AB: Oxidative burst and NO generation as initial response to ischemia in flow-adapted endothelial cells. Am. J. Physic] Heart Circ. Physiol. (2001) 280(5):H2126–H2135.
   Google Scholar
• PETERS DG, ZHANG XC, BENOS PV, HEIDRICH-O'HARE E, FERRELL RE: Genomic analysis of immediate/early response to shear stress in human coronary artery endothelial cells. Physic] Cenomics (2002) 12(1):25–33.
   Google Scholar
• RIZZO V, MORTON C, DEPAOLA N, SCHNITZER JE, DAVIES PF: Recruitment of endothelial caveolae into mechanotransduction pathways by flow conditioning in vitro. Am. I Physiol. Heart Circ. Physic] (2003) 285(4):H1720–H1729.
   Google Scholar
• DURR E, YU J, KRASINSKA KM et al Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat. Biotechnol. (2004) 22(8):985–992.
   Google Scholar
• AIRD WC: Endothelial cell heterogeneity. nit. Care Med. (2003) 31(4 Suppl.):5221–5230.
   Google Scholar
• PASSERINI AG, POLACEK DC, SHI C et al Coexisting proinflammatory and antioxidative endothelial transcription profiles in a disturbed flow region of the adult porcine aorta. Proc. Natl. Acad. Li. USA (2004) 101(8):2482–2487.
   Google Scholar
• SMIRNOV VN, DOMOGATSKY SP, DOLGOV VV et al Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. Proc. Natl. Acad. Sri. USA (1986) 83(17):6603–6607.
   Google Scholar
• CROIX B, RAGO C, VELCULESCU V et al Genes expressed in human tumor endothelium. Science (2000) 289(5482):1197–1202.
   Google Scholar
• PARDRIDGE WM: Molecular biology of the blood-brain barrier. Mol. Biotechnol. (2005) 30(1):57–70.
   Google Scholar
• BRUNEEL A, LABAS V, MAILLOUX A et al Proteomic study of human umbilical vein endothelial cells in culture. Proteomics (2003) 3(5):714–723.
   Google Scholar
• SPRENGER RR, SPEIJER D, BACK JW et al Comparative proteomics of human endothelial cell caveolae and rafts using two-dimensional gel electrophoresis and mass spectrometry. Electrophoresis (2004) 25(1):156–172.
   Google Scholar
• FRANZEN B, DUVEFELT K, JONSSON C et al Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-alpha. Bran] Res. Mol. Brain Res. (2003) 115(2):130–146.
   Google Scholar
• BLANCAFORT P, MAGNENAT L, BARBAS CE 3RD: Scanning the human genome with combinatorial transcription factor libraries. Nat. Biotechnol. (2003) 21(3):269–274.
   Google Scholar
• JACOBSON BS, SCHNITZER JE, MCCAFFERY M, PALADE GE: Isolation and partial characterization of the luminal plasmalemma of microvascular endothelium from rat lungs. Eur. J. Cell Biol. (1992) 58(2):296–306.
   Google Scholar
• •This paper describes the methodology of isolation of endothelial plasmalemma and its specific domains using perfusion of silica beads in isolated rat lungs. This method provided a background for endothelial plasma membrane proteomics employed recently by Schnitzer et al. for identification of potential target determinants for vascular immunotargeting.
   Google Scholar
• OH P, LI Y, YU J et a]: Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 429(6992):629–635.
   Google Scholar
• •This recent paper from one of the leading groups in the field describes a strategy for the identification of potential endothelial target determinants using proteomics of isolated endothelial plasma membranes, gives several examples of targeted delivery of active cargos to the pulmonary vasculature and rats, and provides massive reference materials on presentation of diverse determinants in specific endothelial domains.
   Google Scholar
• JACOBSON BS, STOLZ DB, SCHNITZER JE: Identification of endothelial cell-surface proteins as targets for diagnosis and treatment of disease. Nat. Med. (1996) 2(4):482–484.
   Google Scholar
• SCHNITZER JE: Vascular targeting as a strategy for cancer therapy. N Engl. I Med. (1998) 339(7):472–474.
   Google Scholar
• SKIDGEL RA: Bradykinin-degrading enzymes: structure, function, distribution, and potential roles in cardiovascular pharmacology. Cardiovasc. Pharmacol. (1992) 20\(Suppl. 9):S4–S9.
   Google Scholar
• PASQUALINI R, ARAP W, MCDONALD DM: Probing the structural and molecular diversity of tumor vasculature. Trends Mol. Med. (2002) 8(12):563–571.
   Google Scholar
• PASQUALINI R, MCDONALD DM, ARAP W: Vascular targeting and antigen presentation. Nat. Immunol. (2001) 2(7):567–568.
   Google Scholar
• •This and subsequent paper provide a review of an original strategy developed by this group for the identification of determinants expressed on normal and pathologically altered endothelial cells in diverse organs and vascular areas. It employs in vivo administration of phage libraries displaying high numbers of diverse specific peptides and selecting peptides providing specific targeting of phages in the area of interest.
   Google Scholar
• RAJOTTE D, ARAP W, HAGEDORN M et al Molecular heterogeneity of the vascular endothelium revealed by in vivophage display. Cl/n. Invest. (1998) 102(2):430–437.
   Google Scholar
• HOUSTON P, GOODMAN J, LEWIS A, CAMPBELL CJ, BRADDOCK M: Homing markers for atherosclerosis: applications for drug delivery, gene delivery and vascular imaging. FEBS Lett. (2001) 492(1–2):73-77.
   Google Scholar
• BELIZAIRE AK, TCHISTIAKOVA L, ST-PIERRE Y, ALAKHOV V: Identification of a murine ICAM-1-specific peptide by subtractive phage library selection on cells. Biochem. Biophys. Res. Commun. (2003) 309(3):625–630.
   Google Scholar
• LIU C, BHATTACHARJEE G, BOISVERT W, DILLEY R, EDGINGTON T: In vivo interrogation of the molecular display of atherosclerotic lesion surfaces. Am. Pathol. (2003) 163(5):1859–1871.
   Google Scholar
• SCHLUESENER HJ, XIANGLIN T: Selection of recombinant phages binding to pathological endothelial and tumor cells of rat glioblastoma by in-vivo display. Neurol. Sci (2004) 224(1-2):77–82.
   Google Scholar
• KENNEL SJ, LANKFORD T, FOOTE L, WALL M, DAVERN S: Phage display selection of scFv to murine endothelial cell membranes. Hybrid Hythidomics (2004) 23(4):205–211.
   Google Scholar
• SMITH J, KONTERMANN RE, EMBLETON J, KUMAR S: Antibody phage display technologies with special reference to angiogenesis. FASEB J. (2005) 19(3):331–341.
   Google Scholar
• KELLY KA, ALLPORT JR, TSOURKAS A et al Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ. Res. (2005) 96(3):327–336.
   Google Scholar
• NANDA A, BUCKHAULTS P, SEAMAN S et al Identification of a binding partner for the endothelial cell surface proteins TEM7 and TEM7R. Cancer Res. (2004) 64(23):8507–8511.
   Google Scholar